Télécharger le document - Eurosfaire
Télécharger le document - Eurosfaire
Télécharger le document - Eurosfaire
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
16 / 17<br />
The European Framework Programme:<br />
RSL, IAI and ATCT:<br />
Improving aircraft maintenance<br />
Investment: 40 Million Euro<br />
Key Partners: Daim<strong>le</strong>r-Chrys<strong>le</strong>r, Tha<strong>le</strong>s, A<strong>le</strong>nia, SAGEM, BAE,<br />
Airbus, Marconi and others.<br />
Airlines spend some 20% of operating costs on maintenance, but<br />
it is possib<strong>le</strong> to reduce these costs. Mechanics spend some 30%<br />
of their time trying to locate malfunctions, and human errors in<br />
maintenance are responsib<strong>le</strong> for 15% of all accidents. The goal<br />
of the TATEM project is to recognize and corroborate the use of<br />
various techniques and technologies to make aircraft maintenance<br />
more efficient.<br />
Wisair: Pervasive UWB low spectral radio<br />
Investment: 37.2 Million Euro<br />
Key Partners: Motorola, Tha<strong>le</strong>s, STMicroe<strong>le</strong>ctronics, Mitsubishi,<br />
Te<strong>le</strong>phonica, France Te<strong>le</strong>com and others.<br />
Wisair is participating in the PULSERS consortium, a strategic<br />
and prestigious project of the EU's Sixth Framework. The goal<br />
is the development of ultra-wide-band technology for wire<strong>le</strong>ss<br />
communications, including technology, infrastructure, applications,<br />
regulations, locating UWB technologies and more. The project's<br />
importance has <strong>le</strong>d to the involvement of key international<br />
industries.<br />
IS-4 International:<br />
Responding to airborne threats<br />
Investment: 36 Million Euro<br />
Key Partners: Siemens, Rockwell, Airbus, BAE, Tha<strong>le</strong>s, EADS,<br />
Gali<strong>le</strong>o Avionics and others.<br />
Leading European aerospace firms have invited the Israeli IS-4 to<br />
join the SAFEE consortium, <strong>le</strong>d by the French SAGEM company.<br />
The consortium's goal is to develop new methods and technologies<br />
to improve in-flight security, particularly against terror threats. The<br />
goal of the consortium members is to ensure that every plane will<br />
comp<strong>le</strong>te its journey safely. The infrastructure under development<br />
includes sensors, communication systems and command and<br />
control systems capab<strong>le</strong> of dealing with in-flight threats.<br />
Apnano: Nanopartic<strong>le</strong>s for<br />
machine parts<br />
Investment: 19 Million Euro<br />
Key Partners: Uppsala University (Sweden), Newcast<strong>le</strong> University<br />
(UK), EADS, Rolls-Royce, the French Atomic Energy Committee<br />
and others.<br />
The Foremost Project is based upon Israeli technologies developed<br />
at the Weizmann Institute, with applications developed by Apnano,<br />
a producer of nanometric tubes and materials from non-organic<br />
compounds. These materials are exceptionally resistant to abrasion,<br />
Stories of<br />
pressure and heat, and Apnano has developed the capacity to<br />
mass produce them. The consortium examines ways to use these<br />
materials as coatings for engineering surfaces and as lubricants,<br />
to save energy and improve performance of machine parts (in<br />
aviation, automotive, energy production and heavy industry).<br />
BioKine Therapeutics: Innovative<br />
Treatments for Autoimmune Diseases<br />
Investment: 18.8 Million Euro<br />
Key Partners: Pierre and Marie Curie University (Paris), Munich<br />
University, Lodz Medical School, Novartis and others.<br />
The INNOCHEM consortium comprises a large number of research<br />
and industrial groups focusing on new chemo-kine-based treatments<br />
for autoimmunity and chronic inflammation. After five years,<br />
clinical trials will be held. BioKine is located in Rehovot.<br />
Theravir and the Hebrew University:<br />
Advancing Genetics in Medicine<br />
Investment: 18 Million Euro<br />
Key Partners: Bologna Technological Institute, The Czech Institute<br />
for Mo<strong>le</strong>cular Genetics, Ulm University (Germany), and others.<br />
The CLINIGENE consortium was founded with the aim of<br />
establishing a European network of researchers and industrialists<br />
in medical genetic research. The shared goal is to advance gene<br />
therapy through the development of safe and reliab<strong>le</strong> systems.<br />
The network also focuses on gene transfer and the integration of<br />
studies and multidisciplinary developments in the treatment and<br />
mobilization of genes. A full range of organizations are involved<br />
in developing genetically based medical products and treatments.<br />
These include academia, industry, regulatory bodies, clinics and<br />
hospitals.<br />
Technion and ColorChip: Nanometric<br />
Structures<br />
Investment: 16.7 Million Euro<br />
Key Partners: Fraunhofer, Phillips, Carl Zeiss (Germany), the<br />
French Atomic Energy Committee and others.<br />
The CHARPAN consortium advances innovative technology in<br />
processing materials through multip<strong>le</strong> ion beams, developed by<br />
the Austrian IMS company. The technology has many potential<br />
applications, among them: production of camera micro-<strong>le</strong>nses to<br />
creating templates for nano-etching technology, fabrication of<br />
biological and chemical components for nano-labs and improving<br />
the production process for e<strong>le</strong>ctronic components. The aim is<br />
to develop solutions for the production of minuscu<strong>le</strong>, comp<strong>le</strong>x<br />
three-dimensional templates with precision at a nanometric <strong>le</strong>vel.<br />
A follow-up project, involving the Technion in operation.